Robert J. Lonigro
About
In The Last Decade
Robert J. Lonigro
36 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Molecular Biology 2.5k
- Pulmonary and Respiratory Medicine 1.6k
- Cancer Research 1.5k
- Oncology 742
- Surgery 333
Countries citing papers authored by Robert J. Lonigro
This map shows the geographic impact of Robert J. Lonigro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Lonigro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Lonigro more than expected).
Fields of papers citing papers by Robert J. Lonigro
This network shows the impact of papers produced by Robert J. Lonigro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Lonigro. The network helps show where Robert J. Lonigro may publish in the future.
Co-authorship network of co-authors of Robert J. Lonigro
This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Lonigro. A scholar is included among the top collaborators of Robert J. Lonigro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Lonigro. Robert J. Lonigro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer breakdown → | 384 |
| 3 | 12 | |
| 4 | 2 | |
| 5 | 112 | |
| 6 | Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment breakdown → | 271 |
| 7 | 206 | |
| 8 | 12 | |
| 9 | 116 | |
| 10 | 67 | |
| 11 | 35 | |
| 12 | 55 | |
| 13 | 26 | |
| 14 | 130 | |
| 15 | 6 | |
| 16 | Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer breakdown → | 833 |
| 17 | 303 | |
| 18 | 121 | |
| 19 | Course of FEV1 after Onset of Bronchiolitis Obliterans Syndrome in Lung Transplant Recipients | 6 |
| 20 | 76 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.